Cannabis Law Report

SEPTEMBER 24, 2019

billion by the end of 2025, according to a new report by Grand View Research, Inc. Increasing need for pain management therapies and growing disease burden of chronic pain among elders is also expected to boost demand. from 2019 to 2025. from 2019 to 2025. from 2019 to 2025. Chronic Pain.

Chronic Pain 40

Chronic Pain Legalization Marijuana Pharmaceutical 40

Miss Marijuana

FEBRUARY 1, 2025

In cannabis, terpenes are formed in the trichomes (those tiny little crystals you see on the buds) and are influenced by the plant’s genetics, growing conditions, and stage of life. So, if you’re dealing with chronic pain or just some aches and pains, beta-caryophyllene is one terpene you definitely want in your corner.

Terpenes 52

Terpenes Strains Wellness and Beauty Cannabinoids 52

Veriheal

MARCH 24, 2023

Under the bill, those with chronic pain, cancer, epilepsy, PTSD, and other chronic illnesses would be eligible to receive a medical cannabis card. If passed, the bill will take effect starting in January 2025. 1, 2025 deadline. This is not the first time that Kentucky has attempted to legalize medical cannabis.

Chronic Pain 52

Chronic Pain Epilepsy Cannabis Decriminalization 52

Veriheal

MAY 7, 2021

The measure would allow for more qualifying conditions such as cancer, all forms of PTSD, not just combat-related, chronic pain, and any debilitating conditions that severely impact one’s quality of life. . Next in news, . This would be a game-changer for many Texans! .

Therapy 52

Therapy Education Chronic Pain Decriminalization 52

The Joint Blog

NOVEMBER 21, 2022

While some are quick to criticize it and point out its allegedly adverse effects, habitual users swear by it as an often miracle cure for a plethora of conditions. Indeed, only in the United States, it is projected to hit $16 billion by 2025. Hemp reduces inflammation, easing joint pain and stiffness and promoting joint health.

Consumption 52

Consumption CBD Research and Development Topical 52

Cannabis Law Report

FEBRUARY 18, 2020

Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. In 2018, the New York legal cannabis market reached $1.8

Marijuana 59

Marijuana Consumption Dispensary Vaping 59

Cannabis Law Report

SEPTEMBER 10, 2019

Instead, CBD is fast garnering a reputation in the medical world as a potentially soothing treatment for conditions like arthritis, epilepsy , mental stress, or muscle pain, even as for certain forms of cancer.). billion by the end of 2025, according to a report released by Grand View Research, Inc. No Guarantees.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

Cannabis Law Report

SEPTEMBER 13, 2021

Commenting on the size and scope of the market for delaying aging, Dr. Chapman added, “There are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 1 according to a major investment bank.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Therapy 40

Cannabis Law Report

NOVEMBER 16, 2021

The market for treating aging disorders and extending healthy lifespan is expected to be at least $600 billion by 2025 1 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Veriheal

JUNE 19, 2025

A 2025 BBC report revealed that at least 382 families, identified through online forums and interviews conducted by the parent support charity MedCan, are sourcing cannabis medicines illegally—many to manage severe forms of epilepsy that conventional treatments have failed to control.

Patients 52

Patients Epilepsy Medicine Access 52

Otherside Farms

NOVEMBER 13, 2019

In actuality, experts project that the industry will be worth sixteen billion dollars by the end of 2025. Cannabidiol Alleviates Chronic Pain. Do you suffer any pain concerns? For the record, the compound eliminates inflammation, hence chronic pain. Chronic pain also causes insomnia.

CBD 53

CBD Chronic Pain Blood Pressure Sleep 53

Cannabis Law Report

OCTOBER 20, 2019

The pharmaceutical industry would likely have significant opportunities to develop new cannabinoid-based drugs for a multitude of medical conditions now being addressed by medical marijuana. For example, there is a growing body of evidence that marijuana is working for chronic pain. Westwood, and J. Kleignen, 2015. xv] [link].

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

JANUARY 5, 2022

3 MyMD believes that there are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 40

Pharmaceutical Clinical Trials Therapy Treatment 40

Cannabis Law Report

MAY 19, 2019

billion dollars by 2025. Some conditions like lung cancer and Emphysema have been shown to regress when cannabis is thrown to the mix. It can improve skin conditions and treat skin conditions like eczema vide cannabis topical. Thailand’s cannabis is one of the country’s largest exports. Health Benefits of Cannabis.

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law 40

Law Seed-To-Sale Hemp Recreational 40